Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.

Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE Study Investigator Group.

JAMA Ophthalmol. 2015 Sep;133(9):1022-9. doi: 10.1001/jamaophthalmol.2015.1823.

PMID:
26086920
2.

The role of atopy in corneal graft survival in keratoconus.

Thomas JK, Guel DA, Thomas TS, Cavanagh HD.

Cornea. 2011 Oct;30(10):1088-97. doi: 10.1097/ICO.0b013e31820d8556.

3.

Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.

Giuliari GP, Guel DA, Cortez MA, Cortez RT.

Can J Ophthalmol. 2010 Oct;45(5):501-8. doi: 10.3129/i10-023. Review.

PMID:
20648074
4.

Confluent laser photocoagulation for the treatment of retinopathy of prematurity.

Gonzalez VH, Giuliari GP, Banda RM, Guel DA, Wingard M.

J Pediatr Ophthalmol Strabismus. 2010 Mar-Apr;47(2):81-5; quiz 86-7. doi: 10.3928/01913913-20100308-05. Epub 2010 Mar 22. Erratum in: J Pediatr Ophthalmol Strabismus. 2010 Sep-Oct;47(5):316. Guell, David A [corrected to Guel, David A].

PMID:
20349899
5.

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.

Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M; SCORE Study Research Group.

Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233. Erratum in: Arch Ophthalmol. 2009 Dec;127(12):1655.

6.

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH; SCORE Study Research Group.

Arch Ophthalmol. 2009 Sep;127(9):1101-14. doi: 10.1001/archophthalmol.2009.234. Erratum in: Arch Ophthalmol. 2009 Dec;127(12):1648.

7.

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy.

González VH, Giuliari GP, Banda RM, Guel DA.

Br J Ophthalmol. 2009 Nov;93(11):1474-8. doi: 10.1136/bjo.2008.155663. Epub 2009 Aug 18.

PMID:
19692371
8.

Pegaptanib sodium for the treatment of proliferative diabetic retinopathy and diabetic macular edema.

Giuliari GP, Guel DA, Gonzalez VH.

Curr Diabetes Rev. 2009 Feb;5(1):33-8. Review.

PMID:
19199896
9.

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network.

Ophthalmology. 2008 Sep;115(9):1447-9, 1449.e1-10. doi: 10.1016/j.ophtha.2008.06.015. Epub 2008 Jul 26.

Supplemental Content

Loading ...
Support Center